+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Menopausal Disorders (MD) - Competitive Landscape - Product Thumbnail Image

Menopausal Disorders (MD) - Competitive Landscape

  • Report
  • November 2023
  • 75 Pages
  • Global
From
From
Conjugate Vaccine Market Report and Forecast 2023-2031 - Product Thumbnail Image

Conjugate Vaccine Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cholera Vaccines Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cholera Vaccines Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
HIF-1 Alpha Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

HIF-1 Alpha Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Activating Factor (BAFF) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CD 40 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CD 40 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta-3 Receptors Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-3 Receptors Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator